229 related articles for article (PubMed ID: 15966133)
1. Anti-Mi-2 antibodies.
Ghirardello A; Zampieri S; Iaccarino L; Tarricone E; Bendo R; Gambari PF; Doria A
Autoimmunity; 2005 Feb; 38(1):79-83. PubMed ID: 15966133
[TBL] [Abstract][Full Text] [Related]
2. Anti-Jo-1 antibodies.
Zampieri S; Ghirardello A; Iaccarino L; Tarricone E; Gambari PF; Doria A
Autoimmunity; 2005 Feb; 38(1):73-8. PubMed ID: 15804708
[TBL] [Abstract][Full Text] [Related]
3. Autoantibodies to Mi-2 alpha and Mi-2 beta in patients with idiopathic inflammatory myopathy.
Richards M; García-De La Torre I; González-Bello YC; Vázquez-Del Mercado M; Andrade-Ortega L; Medrano-Ramírez G; Navarro-Zarza JE; Maradiaga-Ceceña M; Loyo E; Rojo-Mejía A; Gómez G; Seaman A; Fritzler MJ; Koenig M; Mahler M
Rheumatology (Oxford); 2019 Sep; 58(9):1655-1661. PubMed ID: 30938432
[TBL] [Abstract][Full Text] [Related]
4. Anti-SAE antibodies in autoimmune myositis: identification by unlabelled protein immunoprecipitation in an Italian patient cohort.
Tarricone E; Ghirardello A; Rampudda M; Bassi N; Punzi L; Doria A
J Immunol Methods; 2012 Oct; 384(1-2):128-34. PubMed ID: 22884621
[TBL] [Abstract][Full Text] [Related]
5. Myositis-specific and myositis-associated autoantibodies in Indian patients with inflammatory myositis.
Srivastava P; Dwivedi S; Misra R
Rheumatol Int; 2016 Jul; 36(7):935-43. PubMed ID: 27193471
[TBL] [Abstract][Full Text] [Related]
6. Myositis-specific autoantibodies and their association with malignancy in Italian patients with polymyositis and dermatomyositis.
Ceribelli A; Isailovic N; De Santis M; Generali E; Fredi M; Cavazzana I; Franceschini F; Cantarini L; Satoh M; Selmi C
Clin Rheumatol; 2017 Feb; 36(2):469-475. PubMed ID: 27761751
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and antigen specificity of anti-histone antibodies in patients with polymyositis/dermatomyositis.
Kubo M; Ihn H; Yazawa N; Sato S; Kikuchi K; Tamaki K
J Invest Dermatol; 1999 May; 112(5):711-5. PubMed ID: 10233761
[TBL] [Abstract][Full Text] [Related]
8. The diagnostic utility of myositis autoantibody testing for predicting the risk of cancer-associated myositis.
Chinoy H; Fertig N; Oddis CV; Ollier WE; Cooper RG
Ann Rheum Dis; 2007 Oct; 66(10):1345-9. PubMed ID: 17392346
[TBL] [Abstract][Full Text] [Related]
9. Autoantibodies in adult patients with idiopathic inflammatory myopathies in Buenos Aires.
Gómez GN; Gargiulo Mde L; Pérez N; Collado MV; Suárez LV; Khoury M; Sarano JF
Medicina (B Aires); 2016; 76(3):129-34. PubMed ID: 27295700
[TBL] [Abstract][Full Text] [Related]
10. Clinical and serological characteristics of 125 Dutch myositis patients. Myositis specific autoantibodies aid in the differential diagnosis of the idiopathic inflammatory myopathies.
Hengstman GJ; Brouwer R; Egberts WT; Seelig HP; Jongen PJ; van Venrooij WJ; van Engelen BG
J Neurol; 2002 Jan; 249(1):69-75. PubMed ID: 11954871
[TBL] [Abstract][Full Text] [Related]
11. [How can we diagnose and better understand inflammatory myopathies? The usefulness of auto-antibodies].
Sibilia J; Chatelus E; Meyer A; Gottenberg JE; Sordet C; Goetz J
Presse Med; 2010 Oct; 39(10):1010-25. PubMed ID: 20655695
[TBL] [Abstract][Full Text] [Related]
12. Classification, diagnosis, and management of idiopathic inflammatory myopathies.
Lazarou IN; Guerne PA
J Rheumatol; 2013 May; 40(5):550-64. PubMed ID: 23504386
[TBL] [Abstract][Full Text] [Related]
13. [New insights of myositis-specific and -associated autoantibodies in juvenile and adult type myositis].
Váncsa A; Dankó K
Orv Hetil; 2016 Jul; 157(30):1179-84. PubMed ID: 27452067
[TBL] [Abstract][Full Text] [Related]
14. Autoantibodies in inflammatory myopathies.
Garlepp MJ; Mastaglia FL
Am J Med Sci; 2000 Apr; 319(4):227-33. PubMed ID: 10768607
[No Abstract] [Full Text] [Related]
15. Clinical Utility of an Enzyme-Linked Immunosorbent Assay for Detecting Anti-Melanoma Differentiation-Associated Gene 5 Autoantibodies.
Sato S; Murakami A; Kuwajima A; Takehara K; Mimori T; Kawakami A; Mishima M; Suda T; Seishima M; Fujimoto M; Kuwana M
PLoS One; 2016; 11(4):e0154285. PubMed ID: 27115353
[TBL] [Abstract][Full Text] [Related]
16. Immunoserological aspects of idiopathic inflammatory muscle disease.
Rozman B; Bozic B; Kos-Golja M; Plesivcnik-Novljan M; Kveder T
Wien Klin Wochenschr; 2000 Aug; 112(15-16):722-7. PubMed ID: 11020964
[TBL] [Abstract][Full Text] [Related]
17. Dermatomyositis. Diagnosis and evaluation of dermatomyositis, polymyositis, and inclusion-body myositis.
Krajnc I
Adv Exp Med Biol; 1999; 455():181-6. PubMed ID: 10599341
[TBL] [Abstract][Full Text] [Related]
18. Hyperacute muscle weakness in an unusual coexistence of antisignal recognition particle and anti-Mi-2 antibodies.
Akintayo RO; Agbola OF; Adeyemo AW; Adelowo O
BMJ Case Rep; 2017 Jul; 2017():. PubMed ID: 28720599
[TBL] [Abstract][Full Text] [Related]
19. [Inflammatory myopathies from internist's perspective].
Genth E
Internist (Berl); 2000 May; 41(5):445-54. PubMed ID: 10867900
[No Abstract] [Full Text] [Related]
20. [Immunologic tests: Anti-polymyositis-scleroderma (PM-Scl) antibody].
Takasaki Y
Nihon Rinsho; 2005 Jul; 63 Suppl 7():502-4. PubMed ID: 16111314
[No Abstract] [Full Text] [Related]
[Next] [New Search]
